Free shipping on orders of $150 or more · Clinic & wholesale pricing available
TRYINSTAMED
Education · Compounds

NAD+: What It Is, Why Levels Decline, and the Delivery Question

NAD+ explained: what the coenzyme does, why levels fall with age, and the delivery math behind precursors, sublingual strips, and IV drips.

LAST REVIEWED 2026-08-16READ TIME ~9 MINEDUCATIONAL — NOT A PRODUCT PAGEBY NICK PETRUCCI, FOUNDER
A woman in her early 40s with natural realistic skin resting at the pool edge after a swim, arms folded on the coping, genuinely energized smile, water droplets on her shoulders

Short answer: NAD+ (nicotinamide adenine dinucleotide) is a coenzyme in every living cell, supporting cellular energy production, mitochondrial performance and the enzymes behind DNA repair. Levels decline with age, which is why restoring them became a major research area. Supporting healthy NAD+ levels may help support energy and cellular resilience.

NAD+ is the molecule your cells spend on everything — and one of the most talked-about in wellness for good reason. This page is the hub for everything we publish on NAD+, NMN, and NR: what the molecule does, why levels fall, and how the delivery formats stack up. If you've been hearing about NAD+ at the gym, on podcasts, or from your most energetic friend, here's the whole picture.

What NAD+ actually is

NAD+ is a coenzyme — a small helper molecule — present in every cell of your body. It cycles between two forms: NAD+ (the oxidized, "empty" form) and NADH (the reduced, "loaded" form). Together they act as an electron shuttle inside your mitochondria, the structures that convert food into ATP — the energy currency cells spend on everything they do. Think of NAD+ as the fleet of delivery trucks your cellular economy runs on.

That shuttle role is only half the story. NAD+ is also a consumed substrate — literally used up — by enzyme families involved in cellular housekeeping:

  • Sirtuins (SIRT1–7), which regulate gene expression and stress responses
  • PARPs, which consume NAD+ while repairing damaged DNA
  • CD38, an enzyme whose activity rises with age and drains NAD+

So NAD+ sits at the crossroads of energy metabolism and cellular maintenance. That dual role is the entire reason it's interesting to aging research — and to anyone who wants their cells to keep up with their calendar.

Why NAD+ levels decline with age

Measured NAD+ levels in human tissue trend downward as we get older — one of the more robust findings in the field, observed across multiple tissue types [published human data]. Two things drive it:

  1. Production slows. Your body builds NAD+ from dietary precursors — niacin and nicotinamide (forms of vitamin B3), and tryptophan — and recycles it through the salvage pathway. Both become less efficient with age.
  2. Consumption rises. Enzymes like CD38 and PARPs consume more NAD+ in older tissue.

Declining NAD+ is associated with the reduced cellular energy capacity and slower repair that characterize aging tissue — which is exactly why researchers are actively studying whether restoring NAD+ levels supports how people feel and function as the years stack up. InstaMed frames its strip around supporting "healthy cellular energy production," "mitochondrial function and resilience," and "healthy aging pathways" [brand claim — unverified].

The delivery landscape: molecule size is the map

How you get NAD+ up matters, and the science here is genuinely interesting. Whether a molecule crosses a mucous membrane depends heavily on its size and charge:

MoleculeApprox. size (Daltons)Mucosal absorption profile
NAD+ (intact)~663 DaCharged; the challenging case
NMN~334 DaBorderline
NR~255–290 DaBorderline
Niacin~123 DaAbsorbs well
Niacinamide~122 DaAbsorbs well

The headline findings from this landscape:

Precursors work — and the human data proves it. NR and NMN are orally bioavailable, and multiple human trials show oral NR raises measured blood NAD+ — the landmark study being Trammell et al., Nature Communications (2016) [published human data]. Several NMN randomized trials at 250–900 mg/day report similar biomarker increases, and a 2026 head-to-head trial (Christen et al., Nature Metabolism) found both NMN and NR at 1,000 mg/day roughly doubled blood NAD+ [published human data]. The biomarker case for raising NAD+ is real and growing.

The regulatory story is loosening fast. NMN spent three years locked out of the supplement category after the FDA excluded it in November 2022. Then the agency reversed course — concluding in September 2025 that NMN was never lawfully excluded, and formally reinstating its dietary-ingredient status in December 2025 [published regulatory record]. The rules in this space are actively being re-examined, and the momentum is toward more legitimate access, not less.

Sublingual intact NAD+ has early data that's genuinely encouraging. A company-sponsored rat pharmacokinetic study of a sublingual NAD+ wafer (iX Biopharma's SL-NAD+) reported a two-fold rise in peak plasma NAD+ within ten minutes, and a small open-label human pilot (nine healthy adults) reported whole-blood NAD+ rising on average +59% at two weeks and +76% at six weeks [published company data — small, uncontrolled]. Early, uncontrolled, and sponsored — but it's exactly the kind of signal that explains why the sublingual NAD+ category is growing.

To be clear: we do not sell NMN or NR products. We cover them because an honest NAD+ hub can't skip the molecules with the best human data.

The honest context

Here's the passage that doesn't help us sell, kept anyway: the strongest published human evidence for raising NAD+ belongs to swallowed precursors (NR, NMN) — not to sublingual intact NAD+, which is what we sell. The iX Biopharma data is small, uncontrolled, and company-sponsored; no peer-reviewed human pharmacokinetic study exists for our specific strip, and in our own review of the published product data, its lot COA covers appearance, heavy metals, and microbials but no potency table — a gap we've flagged to the manufacturer rather than papered over. What the strip offers in exchange is real: needle-free, pre-measured, seconds-a-day convenience in a category whose other verified routes are pills you swallow or drips you schedule. If you want the product side, here's the Energy NAD+ sublingual strip — 100 mg NAD+ per strip, 30-count, orange flavor, $118 per 30-strip box.

IV NAD+: the clinical context

Before strips, the premium option was IV NAD+ at wellness clinics. Intravenous delivery sidesteps every absorption question — straight into the bloodstream — which is exactly why it's the expensive route: sessions run one to several hours, priced well into the hundreds of dollars, with clinic time and supervision attached. Reported experiences vary widely, and IV NAD+ is not an FDA-approved therapy for any condition.

Strips occupy the opposite end of the convenience spectrum: no needles, no appointments, no clinic pricing. Many users report choosing the strip simply because it's the version they'll actually take every day — and consistency is the whole game in a daily-support category.

For a complementary angle on cellular energy support, MOTS-c — a mitochondrial-derived peptide — is the active in our BOOST MOTS-c strips, now available at open checkout.

The bottom line

NAD+ is real chemistry doing real work in every cell you have, its age-related decline is one of the best-documented findings in the field, and raising levels is a live, fast-moving research area with human biomarker data behind it [published human data]. The strip is the most convenient, needle-free way anyone has ever offered to join that conversation — 100 mg per strip, 30 to a box, orange flavor, seconds a day. The precursor evidence is the strongest on the board and we say so ourselves; the strip's early data is encouraging and its convenience is unmatched. Many users report that the format they stick with is the one that fits the life they already live — and this one fits in a pocket.

---

Explore this cluster

The rest of the NAD+ file: precursors versus the direct molecule, format comparisons, timelines and safety.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

This content is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any new product. Individual results vary.

Frequently asked

NAD+ questions, answered straight

What is NAD+ in simple terms?

A coenzyme in every cell that helps turn food into energy and feeds enzymes involved in DNA repair and cellular maintenance. It cycles between two forms — NAD+ and NADH — like a shuttle carrying electrons.

Why do NAD+ levels drop as we age?

Production from dietary precursors (vitamin B3, tryptophan) becomes less efficient, while NAD+-consuming enzymes like CD38 and PARPs become more active. The result is a steady decline in measured tissue levels [published human data].

Is it better to take NAD+ itself or a precursor like NMN or NR?

On published human evidence, precursors currently have the strongest biomarker data: they're orally bioavailable and demonstrably raise blood NAD+. Sublingual intact NAD+ has encouraging early pilot data and unmatched convenience. We sell the strip and still show you the whole board — you decide with your provider.

Are NAD+ strips the same as NAD+ IV therapy?

No. IV delivery puts NAD+ directly into the bloodstream at clinics, at significant cost and time. Strips are a needle-free, at-home format whose absorption evidence is early-stage. Different routes, different evidence, different price points — and for most people, different levels of "will I actually stick with it."

Keep reading

Related peptides and articles

Peptide LibraryTB-500TB-500 is a synthetic thymosin beta-4 fragment with an intriguing preclinical file and a famous recovery-stack reputation. Here's the full picture.Peptide Librarywhat is SemaxSemax is a Russian-developed heptapeptide (an ACTH 4-7 analog) with a real regional evidence base. What it is, what research shows, and where it appears.Peptide Librarywhat is SelankSelank is a Russian-developed tuftsin-analog heptapeptide studied in stress-adjacent research — the evidence file, formats, and where it appears.BlogSublingual vs Liposomal NMN: A Fair Comparison of Two Oral RoutesSublingual vs liposomal NMN, fairly compared: what each format claims, what the evidence shows, and the dose-size problem neither one solves.BlogDoes Sublingual NMN Work Better Than Capsules?Sublingual NMN: NMN is a borderline-size molecule and oral NMN already raises blood NAD+ in human RCTs. Where the strip route could add value.BlogNMN vs NR: The Definitive ComparisonNMN vs NR compared: molecule size, human trial evidence, the 2026 head-to-head result, and regulatory status through Dec 2025.BlogNMN vs NAD+: Which Should You Take?NMN vs NAD+: NMN survives the gut and has human trials; direct NAD+ skips the conversion step via sublingual delivery. How to choose for your goals.BlogNAD+ vs Its Precursors: NMN, NR, Niacinamide and the Direct RouteNAD+ vs precursors: the molecule-size gradient, why precursors shine on evidence, and where the direct sublingual route fits your goals.BlogNAD+ Side Effects: What Supplement and IV Users ReportNAD+ side effects depend on the route. Precursors have human trials with mild effects, IV has its famous flush, and the strip's early signal is clean.
Browse the full Education hub — every peptide in our catalog, reviewed the same way

Disclaimer. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

This content is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any new product. Individual results vary.